Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area

por Mocchegiani, Federico, Baroni, Gianluca Svegliati, Vivarelli, Marco
Publicado 2020

New Insights into the Role of Oxidative Stress in Scleroderma Fibrosis

por Gabrielli, Armando, Svegliati, Silvia, Moroncini, Gianluca, Amico, Donatella
Publicado 2012

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches

por Benfaremo, Devis, Svegliati, Silvia, Paolini, Chiara, Agarbati, Silvia, Moroncini, Gianluca
Publicado 2022

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine

por Benfaremo, Devis, Agarbati, Silvia, Mozzicafreddo, Matteo, Paolini, Chiara, Svegliati, Silvia, Moroncini, Gianluca
Publicado 2023

Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH

por Svegliati-Baroni, Gianluca, Patrício, Bárbara, Lioci, Gessica, Macedo, Maria Paula, Gastaldelli, Amalia
Publicado 2020

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis

por Paolini, Chiara, Agarbati, Silvia, Benfaremo, Devis, Mozzicafreddo, Matteo, Svegliati, Silvia, Moroncini, Gianluca
Publicado 2022

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study

por Mozzicafreddo, Matteo, Benfaremo, Devis, Paolini, Chiara, Agarbati, Silvia, Svegliati Baroni, Silvia, Moroncini, Gianluca
Publicado 2023

Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review

por Montori, Michele, Baroni, Gialuca Svegliati, Santori, Pierangelo, Di Giampaolo, Catia, Ponziani, Francesca, Abenavoli, Ludovico, Scarpellini, Emidio
Publicado 2023

Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts

por Svegliati, S, Luchetti, MM, Paroncini, P, DiCarlo, A, Bevilacqua, F, Campelli, N, Avvedimento, E, Gabrielli, A
Publicado 2005

Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement

por Patrone, Vania, Puglisi, Edoardo, Cardinali, Marco, Schnitzler, Tobias S., Svegliati, Silvia, Festa, Antonella, Gabrielli, Armando, Morelli, Lorenzo
Publicado 2017

Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients

por Danieli, Maria Giovanna, Verga, Jacopo Umberto, Mezzanotte, Cristina, Terrenato, Irene, Svegliati, Silvia, Bilo, Maria Beatrice, Moroncini, Gianluca
Publicado 2022

Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis

por Agarbati, S., Benfaremo, D., Viola, N., Paolini, C., Svegliati Baroni, S., Funaro, A., Moroncini, G., Malavasi, F., Gabrielli, A.
Publicado 2022

The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma

por Balducci, Daniele, Montori, Michele, De Blasio, Federico, Di Bucchianico, Alessandro, Argenziano, Maria Eva, Baroni, Gianluca Svegliati, Scarpellini, Emidio
Publicado 2023

Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2

por Amico, Donatella, Spadoni, Tatiana, Rovinelli, Marina, Serafini, Marta, D’Amico, Giovanna, Campelli, Nadia, Svegliati Baroni, Silvia, Gabrielli, Armando
Publicado 2015

Metabolomic profile of systemic sclerosis patients

por Murgia, Federica, Svegliati, Silvia, Poddighe, Simone, Lussu, Milena, Manzin, Aldo, Spadoni, Tatiana, Fischetti, Colomba, Gabrielli, Armando, Atzori, Luigi
Publicado 2018

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota

por Mori, Hideki, Svegliati Baroni, Gianluca, Marzioni, Marco, Di Nicola, Francesca, Santori, Pierangelo, Maroni, Luca, Abenavoli, Ludovico, Scarpellini, Emidio
Publicado 2022

Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis

por Bocchino, Marialuisa, Agnese, Savina, Fagone, Evelina, Svegliati, Silvia, Grieco, Domenico, Vancheri, Carlo, Gabrielli, Armando, Sanduzzi, Alessandro, Avvedimento, Enrico V.
Publicado 2010

Pathophysiology of Non Alcoholic Fatty Liver Disease

por Petta, Salvatore, Gastaldelli, Amalia, Rebelos, Eleni, Bugianesi, Elisabetta, Messa, Piergiorgio, Miele, Luca, Svegliati-Baroni, Gianluca, Valenti, Luca, Bonino, Ferruccio
Publicado 2016

P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS?

por Morsia, E., Torre, E., Tarantino, G., Svegliati Baroni, G., Goteri, G., Mancini, S., Tassoni, A., Alessandro, F., Olivieri, A., Rupoli, S.
Publicado 2022

Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors

por Abenavoli, Ludovico, Montori, Michele, Svegliati Baroni, Gianluca, Argenziano, Maria Eva, Giorgi, Francesca, Scarlata, Giuseppe Guido Maria, Ponziani, Francesca, Scarpellini, Emidio
Publicado 2023